FI116899B - Triatsolyylitryptamiinin palladiumkatalysoitu renkaanmuodostus - Google Patents

Triatsolyylitryptamiinin palladiumkatalysoitu renkaanmuodostus Download PDF

Info

Publication number
FI116899B
FI116899B FI964669A FI964669A FI116899B FI 116899 B FI116899 B FI 116899B FI 964669 A FI964669 A FI 964669A FI 964669 A FI964669 A FI 964669A FI 116899 B FI116899 B FI 116899B
Authority
FI
Finland
Prior art keywords
compound
formula
palladium
process according
group
Prior art date
Application number
FI964669A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI964669A0 (fi
FI964669L (fi
Inventor
Robert D Larsen
Thomas R Verhoeven
Cheng Y Chen
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI964669A0 publication Critical patent/FI964669A0/fi
Publication of FI964669L publication Critical patent/FI964669L/fi
Application granted granted Critical
Publication of FI116899B publication Critical patent/FI116899B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Inorganic Insulating Materials (AREA)
FI964669A 1994-05-24 1996-11-22 Triatsolyylitryptamiinin palladiumkatalysoitu renkaanmuodostus FI116899B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24828894 1994-05-24
US08/248,288 US5567824A (en) 1994-05-24 1994-05-24 Palladium catalyzed ring closure of triazolyltryptamine
US9505506 1995-05-19
PCT/US1995/005506 WO1995032197A1 (en) 1994-05-24 1995-05-19 Palladium catalyzed ring closure of triazolyl tryptamine

Publications (3)

Publication Number Publication Date
FI964669A0 FI964669A0 (fi) 1996-11-22
FI964669L FI964669L (fi) 1996-11-22
FI116899B true FI116899B (fi) 2006-03-31

Family

ID=22938473

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964669A FI116899B (fi) 1994-05-24 1996-11-22 Triatsolyylitryptamiinin palladiumkatalysoitu renkaanmuodostus

Country Status (24)

Country Link
US (1) US5567824A (enExample)
EP (1) EP0763032B1 (enExample)
JP (1) JP3947216B2 (enExample)
KR (1) KR100385027B1 (enExample)
CN (2) CN1157390C (enExample)
AT (1) ATE252095T1 (enExample)
AU (1) AU688505B2 (enExample)
DE (1) DE69531939T2 (enExample)
DK (1) DK0763032T3 (enExample)
ES (1) ES2207648T3 (enExample)
FI (1) FI116899B (enExample)
HK (1) HK1041262B (enExample)
HR (1) HRP950304B1 (enExample)
HU (1) HU226460B1 (enExample)
MX (1) MX9605838A (enExample)
NZ (1) NZ285539A (enExample)
PT (1) PT763032E (enExample)
RO (1) RO118586B1 (enExample)
RU (1) RU2138496C1 (enExample)
SK (1) SK284495B6 (enExample)
TW (1) TW300221B (enExample)
UA (1) UA52586C2 (enExample)
WO (1) WO1995032197A1 (enExample)
YU (1) YU49345B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA965837B (en) * 1995-07-11 1997-01-31 Merck & Co Inc A triazolylmethyl-indole ethylamine bisulfate salt
ES2163032T3 (es) * 1995-07-11 2002-01-16 Merck & Co Inc Sal bisulfato de triazolilmetil-indol etilamina.
CZ48299A3 (cs) * 1996-08-13 1999-07-14 Merck & Co., Inc. Způsob výroby indolových derivátů
US5877329A (en) * 1996-08-13 1999-03-02 Merck & Co., Inc. Palladium catalyzed indolization
US5811551A (en) * 1996-08-13 1998-09-22 Merck & Co., Inc. Palladium catalyzed indolization
US5808064A (en) * 1996-08-13 1998-09-15 Merck & Co., Inc. Palladium catalyzed indolization
JP2003503403A (ja) * 1999-06-28 2003-01-28 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 呼吸合胞体ウイルス複製阻害剤
ES2204303B2 (es) * 2002-08-07 2004-12-16 Laboratorios Vita, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo.
CA2552663A1 (en) 2004-01-09 2005-07-28 Ratiopharm Gmbh Crystalline forms of rizatriptan benzoate
ES2340861T3 (es) * 2004-01-28 2010-06-10 Ratiopharm Gmbh Procedimientos de sintesis e intermedios para la fabricacion de rizatriptan.
GT200500065A (es) * 2004-03-26 2005-10-24 Procedimientos para la preparacion de compuestos aminoarilos yodados
WO2006082598A2 (en) * 2005-02-01 2006-08-10 Natco Pharma Limited Novel crystalline forms of rizatriptan benzoate
WO2006137083A1 (en) * 2005-06-20 2006-12-28 Natco Pharma Limited Improved process for the preparation of rizatriptan benzoate
EP1951713A1 (en) * 2005-11-14 2008-08-06 Matrix Laboratories Ltd Process for the large scale production of rizatriptan benzoate
WO2007083320A2 (en) * 2006-01-19 2007-07-26 Matrix Laboratories Ltd Conversion of aromatic diazonium salt to aryl hydrazine
EP2160390A1 (en) * 2007-06-04 2010-03-10 Generics Ýuk¨Limited Novel process
CN108697637A (zh) 2016-01-27 2018-10-23 因斯塔尔科技股份公司 用于治疗性处理的口腔粘膜纳米纤维载体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
CA2084531A1 (en) * 1991-12-19 1993-06-20 David W. Smith Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines
GB9215526D0 (en) * 1992-07-22 1992-09-02 Merck Sharp & Dohme Chemical process

Also Published As

Publication number Publication date
FI964669A0 (fi) 1996-11-22
MX9605838A (es) 1997-12-31
TW300221B (enExample) 1997-03-11
HK1041262B (zh) 2005-04-15
HU226460B1 (en) 2008-12-29
AU2467195A (en) 1995-12-18
RO118586B1 (ro) 2003-07-30
HUT76469A (en) 1997-09-29
CN1322725A (zh) 2001-11-21
SK149896A3 (en) 1997-09-10
EP0763032B1 (en) 2003-10-15
CN1152920A (zh) 1997-06-25
KR970703336A (ko) 1997-07-03
YU49345B (sh) 2005-07-19
DK0763032T3 (da) 2004-02-09
PT763032E (pt) 2004-02-27
HK1009045A1 (en) 1999-05-21
US5567824A (en) 1996-10-22
RU2138496C1 (ru) 1999-09-27
UA52586C2 (uk) 2003-01-15
NZ285539A (en) 1998-06-26
HRP950304B1 (en) 2004-12-31
CN1157390C (zh) 2004-07-14
ES2207648T3 (es) 2004-06-01
FI964669L (fi) 1996-11-22
EP0763032A1 (en) 1997-03-19
SK284495B6 (sk) 2005-05-05
CN1077104C (zh) 2002-01-02
DE69531939T2 (de) 2004-07-29
JP3947216B2 (ja) 2007-07-18
HU9603236D0 (en) 1997-01-28
KR100385027B1 (ko) 2003-08-14
YU33495A (sh) 1998-07-10
DE69531939D1 (de) 2003-11-20
JPH10500680A (ja) 1998-01-20
WO1995032197A1 (en) 1995-11-30
HRP950304A2 (en) 1997-08-31
HK1041262A1 (en) 2002-07-05
ATE252095T1 (de) 2003-11-15
AU688505B2 (en) 1998-03-12

Similar Documents

Publication Publication Date Title
RU2138496C1 (ru) Способ получения 5-(1,2,4-триазол-1-ил)триптаминовых соединений и 2-[5-(1,2,4-триазол-1-ил- метил)-1н-индол-3-ил/этиловый спирт
LU84895A1 (fr) Derives n-imidazolyliques de composes bicycliques et leur procede de preparation
FI71310C (fi) Foerfarande foer framstaellning av som laekemedel anvaenda imidazolylvinyletrar med baktericid och fungicid verkan
Miyabe et al. Radical addition to oxime ethers for asymmetric synthesis of β-amino acid derivatives
US20050209294A1 (en) Process for producing 4-(1H-1,2,4-triazol-1-ylmethyl)benzonitrile
EA003244B1 (ru) Катализируемая палладием индолизация
US20090203922A1 (en) Process for Synthesizing 2-Phenyl-1H-Phenanthro[9,10-d]Imidazole Derivative
JPH08283261A (ja) ３−フェニルトリアゾール誘導体および殺虫、殺ダニ剤
CA2190851C (en) Palladium catalyzed ring closure of triazolyl tryptamine
US7094904B2 (en) Process for preparing monohydrate and crystal modifications of fluconazole
HK1009045B (en) Palladium catalyzed ring closure of triazolyl tryptamine
EP1044193B1 (en) Process for preparing triazole antimycotic compounds
JPH07278121A (ja) １ｈ−１，２，３−トリアゾ−ルの製法
WO1999029676A1 (en) Process for preparing triazole compounds
FR2583048A1 (fr) Derives de pyrrolo (3,2,1-hi) indole, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116899

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: MERCK SHARP & DOHME CORP.

Free format text: MERCK SHARP & DOHME CORP.

PC Transfer of assignment of patent

Owner name: MERCK SHARP & DOHME CORP.

MA Patent expired